Evidence map›Paper›PMID 34857762›Full record

ArticleNature communications2021

Spatiotemporal dynamics of SETD5-containing NCoR-HDAC3 complex determines enhancer activation for adipogenesis.

Yoshihiro Matsumura, Ryo Ito, Ayumu Yajima, Rei Yamaguchi, Toshiya Tanaka, Takeshi Kawamura, Kenta Magoori, Yohei Abe, Aoi Uchida, Takeshi Yoneshiro and 20 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

30 authors at 9 institutions in 2 countries.

Yoshihiro Matsumura *Division of Metabolic Medicine, Research Center for Advanced Science and Technology, The University of Tokyo, Tokyo, Japan. matsumura-y@lsbm.org.ORCID http://orcid.org/0000-0002-3108-0440
Ryo Ito *Division of Molecular Physiology and Metabolism, Tohoku University Graduate School of Medicine, Sendai, Japan.
Ayumu Yajima *Division of Metabolic Medicine, Research Center for Advanced Science and Technology, The University of Tokyo, Tokyo, Japan.
Rei YamaguchiDivision of Molecular Physiology and Metabolism, Tohoku University Graduate School of Medicine, Sendai, Japan.
Toshiya TanakaDepartment of Nuclear Receptor Medicine, Laboratories for Systems Biology and Medicine, Research Center for Advanced Science and Technology, The University of Tokyo, Tokyo, Japan.ORCID http://orcid.org/0000-0003-1224-7898
Takeshi KawamuraIsotope Science Center, The University of Tokyo, Tokyo, Japan.
Kenta MagooriDivision of Metabolic Medicine, Research Center for Advanced Science and Technology, The University of Tokyo, Tokyo, Japan.ORCID http://orcid.org/0000-0002-9135-7560
Yohei AbeDivision of Metabolic Medicine, Research Center for Advanced Science and Technology, The University of Tokyo, Tokyo, Japan.ORCID http://orcid.org/0000-0003-2519-4924
Aoi UchidaDivision of Metabolic Medicine, Research Center for Advanced Science and Technology, The University of Tokyo, Tokyo, Japan.
Takeshi YoneshiroDivision of Metabolic Medicine, Research Center for Advanced Science and Technology, The University of Tokyo, Tokyo, Japan.ORCID http://orcid.org/0000-0001-5298-5831
Hiroyuki HirakawaDivision of Metabolic Medicine, Research Center for Advanced Science and Technology, The University of Tokyo, Tokyo, Japan.
Ji ZhangDivision of Metabolic Medicine, Research Center for Advanced Science and Technology, The University of Tokyo, Tokyo, Japan.
Makoto AraiDivision of Metabolic Medicine, Research Center for Advanced Science and Technology, The University of Tokyo, Tokyo, Japan.
Chaoran YangDivision of Molecular Physiology and Metabolism, Tohoku University Graduate School of Medicine, Sendai, Japan.ORCID http://orcid.org/0000-0001-6639-8136
Ge YangDivision of Molecular Physiology and Metabolism, Tohoku University Graduate School of Medicine, Sendai, Japan.
Hiroki TakahashiDivision of Molecular Physiology and Metabolism, Tohoku University Graduate School of Medicine, Sendai, Japan.
Hitomi FujihashiDivision of Metabolic Medicine, Research Center for Advanced Science and Technology, The University of Tokyo, Tokyo, Japan.
Ryo NakakiGenome Science Division, Research Center for Advanced Science and Technology, The University of Tokyo, Tokyo, Japan.
Shogo YamamotoGenome Science Division, Research Center for Advanced Science and Technology, The University of Tokyo, Tokyo, Japan.ORCID http://orcid.org/0000-0002-5564-2567
Satoshi OtaGenome Science Division, Research Center for Advanced Science and Technology, The University of Tokyo, Tokyo, Japan.
Shuichi TsutsumiGenome Science Division, Research Center for Advanced Science and Technology, The University of Tokyo, Tokyo, Japan.
Shin-Ichi InoueDivision of Molecular Physiology and Metabolism, Tohoku University Graduate School of Medicine, Sendai, Japan.ORCID http://orcid.org/0000-0002-0745-3665
Hiroshi KimuraCell Biology Center, Institute of Innovative Research, Tokyo Institute of Technology, Yokohama, Japan.ORCID http://orcid.org/0000-0003-0854-083X
Youichiro WadaIsotope Science Center, The University of Tokyo, Tokyo, Japan.
Tatsuhiko KodamaDepartment of Nuclear Receptor Medicine, Laboratories for Systems Biology and Medicine, Research Center for Advanced Science and Technology, The University of Tokyo, Tokyo, Japan.
Takeshi InagakiDivision of Metabolic Medicine, Research Center for Advanced Science and Technology, The University of Tokyo, Tokyo, Japan.ORCID http://orcid.org/0000-0003-1711-8286
Timothy F OsborneInstitute for Fundamental Biomedical Research, Johns Hopkins All Children's Hospital, and Medicine in the Division of Endocrinology, Diabetes and Metabolism of the Johns Hopkins University School of Medicine, Petersburg, FL, USA.
Hiroyuki AburataniGenome Science Division, Research Center for Advanced Science and Technology, The University of Tokyo, Tokyo, Japan.ORCID http://orcid.org/0000-0003-0438-1544
Koichi NodeDepartment of Cardiovascular Medicine, Saga University, Saga, Japan.ORCID http://orcid.org/0000-0002-2534-0939
Juro SakaiDivision of Metabolic Medicine, Research Center for Advanced Science and Technology, The University of Tokyo, Tokyo, Japan. jmsakai@med.tohoku.ac.jp.ORCID http://orcid.org/0000-0003-4043-1035
The University of Tokyo · JPTohoku University · JPSaga University · JPGunma University · JPJohns Hopkins University · USNational Tax College · JPTokyo Institute of Technology · JPTokyo Medical and Dental University · JPTokyo University of Science · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Enhancer activation is essential for cell-type specific gene expression during cellular differentiation, however, how enhancers transition from a hypoacetylated "primed" state to a hyperacetylated-active state is incompletely understood. Here, we show SET domain-containing 5 (SETD5) forms a complex with NCoR-HDAC3 co-repressor that prevents histone acetylation of enhancers for two master adipogenic regulatory genes Cebpa and Pparg early during adipogenesis. The loss of SETD5 from the complex is followed by enhancer hyperacetylation. SETD5 protein levels were transiently increased and rapidly degraded prior to enhancer activation providing a mechanism for the loss of SETD5 during the transition. We show that induction of the CDC20 co-activator of the ubiquitin ligase leads to APC/C mediated degradation of SETD5 during the transition and this operates as a molecular switch that facilitates adipogenesis.

Indexed as

3T3-L1 CellsAcetylationAdipogenesisAnaphase-Promoting Complex-CyclosomeAnimalsCCAAT-Enhancer-Binding ProteinsCdc20 ProteinsEnhancer Elements, GeneticGene Expression RegulationHEK293 CellsHistone Deacetylase 3Histone DeacetylasesHistonesHumansMethyltransferasesMiceAnaphase-Promoting Complex-CyclosomeCCAAT-Enhancer-Binding ProteinsCdc20 protein, mouseCdc20 ProteinsCEBPA protein, mouseHistone Deacetylase 3Histone DeacetylasesHistonesMethyltransferasesNcor1 protein, mouseNuclear Receptor Co-Repressor 1PPAR gammaPparg protein, mouseSETD5 protein, mouse

Identifiers

PMID34857762
PMCPMC8639990
OpenAlexW3132005222

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.